ACRPO  >> Vol. 2 No. 4 (October 2013)

    卵巢癌合并肾衰1例的治疗体会
    The Experience of the Treatment in One Case of Ovarian Cancer Combined with Renal Failure

  • 全文下载: PDF(139KB) HTML    PP.21-22   DOI: 10.12677/ACRPO.2013.24006  
  • 下载量: 1,133  浏览量: 4,601  

作者:  

董 标:安徽医科大学第二附属医院肿瘤中心,合肥;蒙城县第一人民医院肿瘤科,毫州;
张东远:蒙城县第一人民医院肿瘤科,毫州;
程怀东,解佳奇,陈振东:安徽医科大学第二附属医院肿瘤中心,合肥

关键词:
卵巢癌肾衰化疗Ovarian Cancer; Renal Failure; Chemotherapy

摘要:

卵巢癌是一种生长在卵巢上的恶性肿瘤,早期症状隐匿,多见腹盆腔转移,卵巢癌并发肾衰竭临床较少见,其治疗暂未见相关报道。本文报道卵巢癌合并肾衰经化疗后肾功能恢复正常1例。
Ovarian cancer is one of the malignant tumors which grows in the ovarian, early symptoms concealed, common abdominal and pelvic metastasis, ovarian cancer is less common combined with renal failure, there have been no reports of relevant treatment. This paper reports one case of ovarian cancer combined with renal failure whose renal function restored after chemotherapy.

文章引用:
董标, 张东远, 程怀东, 解佳奇, 陈振东. 卵巢癌合并肾衰1例的治疗体会[J]. 亚洲肿瘤科病例研究, 2013, 2(4): 21-22. http://dx.doi.org/10.12677/ACRPO.2013.24006

参考文献

[1] B. S. Gostout, D. R. Pachman, R. Lechner, et al. Recognizing and treating ovarian cancer. Minnesota Medicine, 2012, 95(3): 40-42.
[2] 赵霞, 钟茜. 卵巢癌早期筛查的争议与展望[J]. 西部医学, 2009, 21(1): 1672-1673.
[3] K. Matsuo. Inferior vena cava filter placement and risk of he- matogenous distant metastasis in ovarian cancer. American Jour- nal of Clinical Oncology, 2013, 36(4): 362-736.
[4] NCCN. 2012 NCCN ovarian cancer including falopian tube cancer and primary peritoneal cancer clinical practice guidelnes. 2nd Edition, l MJ. NCCN, 2012.
[5] 易祥明. 急性肾衰竭血液透析的疗效观察[J]. 医学信息, 2009, 1(12): 94-95.
[6] B. L. Jaber. Apoptosis of leukocytes: Basic concepts and impli- cations in uremia. Kidney International Supplements, 2001, 78: S197-S205.
[7] J. Galloway. Remarks on hondgkin’s disease. British Medical Journal, 1922, 2(3234): 1201-1208.
[8] 顾勇. 肿瘤相关性肾损害[J]. 继续医学教育, 2006, 20(5): 52.
[9] 任玉卿, 姜振华, 史官茂等. 肿瘤合并肾损害35例临床分析[J]. 临床与实践, 2012, 16(32): 4228-4230.
[10] S. Horie. A case of inoperable advanced bile duct cancer treated effectively with combined chemotherapy of gemcitabine and S-1. Gan to Kagaku Ryoho, 2013, 40(2): 259-262.
[11] S. C. Weng. Malignant lymphoma of the kidney mimicking ra- pid progressive glomerulonephritis. Clinical Nephrology, 2010, 74(6): 480-484.
[12] D. J. Pinato. Evolving concepts in the management of drug re- sistant ovarian cancer: Dose dense chemotherapy and the rever- sal of clinical platinum resistance. Cancer Treat Reviews, 2013, 39(2): 153-160.